Search results

From Self-sufficiency
Jump to: navigation, search
  • ...paring effect in inflammatory neurodegenerative diseases such as Alzheimer disease and stroke <ref>{{cite journal |author=Diaz-Ruiz A, Zavala C, Montes S, ''e ...|doi= 10.1016/S0190-9622(82)70014-3|url=}}</ref> an autoimmune blistering disease of skin and mucous membranes, [[dermatitis herpetiformis]] and [[Linear imm
    15 KB (2,087 words) - 16:43, 27 September 2010
  • ...ame [[rember]], may provide a way of halting or slowing the progression of Alzheimer's dementia.<ref name="BBCNews"> | title=Alzheimer's drug 'halts' decline
    27 KB (3,650 words) - 16:46, 27 September 2010
  • ...in a study doses of valproic acid reversed the early stages of Alzheimer's disease in mice. Human trials are underway.{{Citation needed|date=June 2010}} ...me patients with symptomatic but manageable AIDS, cancer, hepatic or renal disease are kept on the medication (usually at a reduced dose with more frequent bl
    25 KB (3,328 words) - 16:47, 27 September 2010
  • ...d primarily to treat [[heart failure]], [[ascites]] in patients with liver disease, low-[[renin]] [[hypertension]], [[hypokalemia]], secondary hyperaldosteron ...neur.63.5.noc60013)</ref>, researchers observed a reduction in the risk of Alzheimer's specifically associated with potassium-sparing diuretics. Unpublished find
    12 KB (1,555 words) - 16:49, 27 September 2010
  • ...f>{{cite journal |author=Perl DP, Moalem S |title=Aluminum and Alzheimer's disease, a personal perspective after 25 years |journal=J. Alzheimers Dis. |volume= ...of epidemiologic studies on aluminum and silica in relation to Alzheimer's disease and associated disorders
    10 KB (1,283 words) - 16:49, 27 September 2010
  • ...send KP, Praticò D |title=Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs |journal=FASEB J. |volume=19 ...|title=Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease |journal=Ann Neurol |volume=58 |issue=6 |pages=963–7 |year=2005 |pmid=162
    29 KB (3,955 words) - 22:17, 21 September 2010
  • ...usto, Nelson|title = Anemia|work = Robbins and Cotran: Pathologic Basis of Disease, 7th edition|publisher = Elsevier Saunders ...iency]] and have consulted a doctor. Hemochromatosis is estimated to cause disease in between 0.3 and 0.8% of Caucasians.<ref>{{cite journal|title=Hereditary
    67 KB (9,808 words) - 10:24, 20 September 2010
  • | [[Alzheimer's Disease]] | [[Adult Refsum disease]]
    19 KB (2,282 words) - 21:04, 21 September 2010
  • ...ral sclerosis|Lou Gehrig's disease]], [[Hartnup disease]] and [[Mortimer's disease]]). ...ver]], [[Brooklyn eye]]) and even societies ([[Legionellosis|Legionnaires' disease]]). These, however, are not eponyms.
    29 KB (3,290 words) - 21:05, 21 September 2010
  • * [[Alois Alzheimer]] — [[Alzheimer's disease]] * [[Karl Adolph von Basedow]] — [[Graves-Basedow disease]]
    31 KB (3,671 words) - 21:06, 21 September 2010
  • ...or and frequently observed [[neurological disorders]] (e.g., [[Alzheimer's disease]]), symptoms (e.g., [[back pain]]), signs (e.g., [[aphasia]]) and syndromes *[[Alexander disease]]
    10 KB (889 words) - 21:07, 21 September 2010
  • A listing of [[disease]]s. [ariharan disease]
    20 KB (1,819 words) - 21:07, 21 September 2010
  • | [[Canavan disease]] | [[Celiac disease]]
    65 KB (7,342 words) - 21:07, 21 September 2010
  • This article is a '''list of [[fiction]]al [[disease]]s''' — nonexistent, named medical conditions which appear in fiction whe ...smission (medicine)|airborne transmission]], and is extremely [[infectious disease|contagious]].
    66 KB (10,587 words) - 21:08, 21 September 2010
  • {{Infobox disease ...uthor=Zamboni P |title=The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis |journal=J R Soc Med |volume=9
    25 KB (3,509 words) - 21:29, 21 September 2010
  • ...inflammation caused by [[Amyloid beta]] proteins involved in [[Alzheimer's Disease]], in addition to preventing cognitive impairment and loss of neuronal mark
    5 KB (653 words) - 22:07, 21 September 2010
  • ...inflammation caused by [[Amyloid beta]] proteins involved in [[Alzheimer's Disease]], in addition to preventing cognitive impairment and loss of neuronal mark ...spec=relevance&resourcetype=HWCIT JNeurosci.org] Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microgli
    4 KB (544 words) - 22:08, 21 September 2010
  • ...inflammation caused by [[Amyloid beta]] proteins involved in [[Alzheimer's Disease]], in addition to preventing cognitive impairment and loss of neuronal mark ...spec=relevance&resourcetype=HWCIT JNeurosci.org] Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microgli
    3 KB (360 words) - 22:08, 21 September 2010
  • New scientific evidence is showing that THC can prevent [[Alzheimer's Disease]] in an [[animal model]] by preventing the inflammation caused by [[microgl |title=Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microgli
    50 KB (6,686 words) - 22:09, 21 September 2010
  • ...el research was being carried out at the time on [[Autoimmunity|autoimmune disease]], cancer, neuroprotection, fever, disorders of blood pressure.<ref name = ...been shown to relieve symptoms of anorexia and reduce agitation in elderly Alzheimer's patients.<ref>{{cite web|url = http://news.bbc.co.uk/1/hi/health/3169901.st
    76 KB (10,798 words) - 22:10, 21 September 2010

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)